Dicerna Pharmaceuticals, Inc.
DRNA
DRNA was delisted on the 27th of December, 2021.
58 hedge funds and large institutions have $185M invested in Dicerna Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
44% more capital invested
Capital invested by funds: $128M → $185M (+$56.4M)
14% more funds holding
Funds holding: 51 → 58 (+7)
6% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.89M |
| 2 |
OPPM
Opus Point Partners Management
New York
|
+$1.14M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$706K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$690K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
+$469K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.01M |
| 2 |
Morgan Stanley
New York
|
-$1.36M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.08M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$821K |
| 5 |
AIC
AWM Investment Company
New York
|
-$657K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Creative Planning
Overland Park,
Kansas
| $59K | +$57.2K | +5,000 | New |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $49K | +$47.7K | +4,167 | New |
|
53
Bank of America
Charlotte,
North Carolina
| $45K | +$41K | +3,582 | +1,643% |
|
54
BNP Paribas Financial Markets
Paris,
France
| $37.5K | +$366 | +32 | +1% |
|
55
UBS Group
Zurich,
Switzerland
| $3K | -$12K | -1,047 | -81% |
|
56
Bank of Montreal
Toronto,
Ontario, Canada
| $2K | +$2.19K | +191 | New |
|
57
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $121 | – | – | – |
|
|
CAM
58
Cormorant Asset Management
Boston,
Massachusetts
| – | -$2.01M | -245,000 | Closed |
|
|
IHM
59
Iguana Healthcare Management
New York
| – | -$821K | -100,000 | Closed |
|
|
AIC
60
AWM Investment Company
New York
| – | -$657K | -80,000 | Closed |
|
61
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$8.01K | -700 | -97% |
|
|
HNB
62
Huntington National Bank
Columbus,
Ohio
| – | -$4K | -500 | Closed |
|
DRNA Hedge Fund Activity: Q4 2015 in Review
58 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Dicerna Pharmaceuticals, Inc. (DRNA) for Q4 2015, worth a combined $185M — up 44% from $128M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new DRNA positions and 4 closed out — a net gain of 7 holders — while 19 added to existing stakes and 18 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $2.89M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $2.01M sold.
- 58 institutional investors held Dicerna Pharmaceuticals, Inc. (DRNA) as of Q4 2015, up from 51 in Q3 2015.
- Funds reported $185M of Dicerna Pharmaceuticals, Inc. stock for Q4 2015, up 44% quarter-over-quarter.
- 11 funds opened new Dicerna Pharmaceuticals, Inc. positions in Q4 2015 and 4 closed out, a net change of +7 holders.
- The largest Dicerna Pharmaceuticals, Inc. buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $2.89M added.
- The largest Dicerna Pharmaceuticals, Inc. seller in Q4 2015 was Cormorant Asset Management, an estimated $2.01M sold.
Based on aggregated 13F filings for Q4 2015.